NF1
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (5)
Total enrollment: 68 patients across 5 trials
A Phase II Trial of Poly-ICLC for Low-Grade Gliomas
A Study of Mirdametinib in People With Central Nervous System Tumors
Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)
Related Jobs
Vice President, Commercial Data, Analytics & Insights
Territory Business Manager - Upstate New York
Territory Business Manager - Columbus, OH / Indianapolis, IN
Director, Business Insights Analytics – Rare Disease
Territory Business Manager - New York City
Territory Business Manager - San Diego
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.